Related Experiment Video
Updated: Jun 5, 2026
07:40
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint
Stephen B Duffull1, Daniel F B Wright, Helen R Winter
1School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand. stephen.duffull@otago.ac.nz
British Journal of Clinical Pharmacology
|January 6, 2011
Summary
Population analysis aids in personalized medicine dosing by identifying patient characteristics that influence drug response. This review simplifies interpreting these complex analyses for better clinical application.
Area of Science:
- Clinical Pharmacology
- Pharmacometrics
- Drug Development
Background:
- Population analysis is crucial for individualizing drug dosing.
- Statistical complexity often hinders the clinical utility of population analyses.
- Covariate identification is a key application for optimizing drug regimens.
Purpose of the Study:
- To provide a guide for interpreting population analysis publications.
- To assist readers in extracting meaningful information from these studies.
- To clarify the importance of covariates for dose individualization.
Main Methods:
- Introduction to the general framework of population analysis.
- Illustrative example with visual plots.
- Detailed interpretation guidelines for covariate identification.
Main Results:
- Provides a structured approach to understanding population analysis outputs.
- Explains how to assess the significance of patient characteristics (covariates).
- Offers insights into the practical implications for adjusting drug doses.
Conclusions:
- Population analysis is an underutilized tool for personalized medicine.
- This review demystifies population analysis interpretation for clinicians.
- Facilitates improved dose individualization through covariate identification.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...